Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment

Journal of Medical Virology

Volumn 56, Issue 1, 1998, Pages 33-38

  Odeberg, Jacob ^a   Yun, Zhibing ^b   Sönnerborg, Anders ^b   Weiland, Ola ^b   Lundeberg, Joakim ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Direct sequencing; Interferon sensitivity; Quasispecies heterogeneity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2B INTERFERON;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DNA SEQUENCE; DRUG EFFICACY; DRUG SENSITIVITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PROGNOSIS; VIRUS LOAD;

AMINO ACID SEQUENCE; GENETIC HETEROGENEITY; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; PHYLOGENY; VARIATION (GENETICS); VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 0031851835     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199809)56:1<33::AID-JMV6>3.0.CO;2-O     Document Type: Article

References (16)

1. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H (1997): Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25:745-749.
2. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C (1994): Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. Journal of General Virolgy 75:1361-1369.
3. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C (1995): Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigation 96:224-230.
4. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C (1996): Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine 334:77-81.
5. Gale M, Korth M, Tang N, Tan S-L, Hopkins D, Dever T, Polyak S, Gretch D, Katze M (1997): Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-227.
6. Hofgärtner WT, Polyak SJ, Sullivan DG, Carithers RL Jr, Gretch DR (1997): Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. Journal of Medical Virology 53:118-126.
7. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A, Capron D, Capron JP, Lunel F, Stuyver L, Duverlie G (1997): Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alpha therapy in French patients. Journal of Hepatology 27:72-77.
8. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC (1993): Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504.
9. Odeberg J, Yun Z, Sönnerborg A, Uhlen M, Lundeberg J (1995): Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing. Journal of Clinical Microbiology 33:1870-1874.
10. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S (1992): The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619-624.
11. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S (1993): Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. Journal of General Virology 74:2385-2390.
12. Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, Brechot C (1997): Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alpha. Gastroenterology 113:567-572.
13. Yun ZB, Lindh G, Weiland O, Johansson B, Sönnerborg A (1993): Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors. Journal of Medical Virology 39:57-61.
14. Yun Z, Lundeberg J, Johansson B, Hedrum A, Weiland O, Uhlen M, Sönnerborg A (1994): Colorimetric detection of competitive PCR products for quantification of hepatitis C viremia. Journal of Virology 47:1-13.
15. Yun ZB, Odeberg J, Lundeberg J, Weiland O, Uhlen M, Sönnerborg A (1996): Restriction of hepatitis C virus heterogeneity during prolonged interferon-alpha therapy in relation to changes in virus load. Journal of Infectious Diseases 173:992-996.
16. Zeuzem S, Lee JH, Roth WK (1997): Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alpha. Hepatology 25:740-744.